There are 3162 resources available
Q&A and discussion
Session: Personalised immunotherapy strategies for head and neck cancers
Resources:
Webcast
Q&A
Session: 9th ESMO Designated Centres of Integrated Oncology and Palliative Care session and awards: Specific considerations for integration of oncology and palliative care
Resources:
Webcast
LBA20 - First-line carboplatin-cyclophosphamide (CC) versus paclitaxel (P) with or without atezolizumab (atezo) for metastatic triple negative breast cancer (mTNBC): Results from a multicenter, randomized phase IIb trial: The Triple-B study (BOOG 2013-01)
Presenter: Marleen Kok
Session: Proffered paper session: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
LBA40 - Primary results from the phase III ALTN-AK105-III-02 study: Anlotinib plus penpulimab versus sorafenib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
Presenter: Jian Zhou
Session: Proffered paper session 1: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
991O - First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors
Presenter: Rachel Sanborn
Session: Proffered paper session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
606O - Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors
Presenter: Funda Meric-Bernstam
Session: Proffered paper session 1: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1723MO - Axitinib plus avelumab in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST) after failure of standard therapy: Single-arm phase II study (AXAGIST)
Presenter: Piotr Rutkowski
Session: Mini oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA19 and LBA20
Presenter: Karen Gelmon
Session: Proffered paper session: Breast cancer, metastatic
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Srikala Sridhar
Session: Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?
Resources:
Webcast
Invited Discussant LBA62 and LBA40
Presenter: Rachna Shroff
Session: Proffered paper session 1: GI tumours, upper digestive
Resources:
Slides
Webcast